Archive: 03/06/2016

AMA module promotes training of medical assistants

(HealthDay)—A new training module can improve training for medical assistants (MAs), according to a report from the American Medical Association (AMA).

Jun 3, 2016

0

0

Contraindication to antiplatelet rx for about 18 percent with PCI

(HealthDay)—About 18 percent of patients undergoing percutaneous coronary intervention (PCI) have a contraindication to commonly used antiplatelet medications, according to a study published online May 31 in Circulation: ...

Jun 3, 2016

0

0

Spironolactone no benefit for knee OA in older adults

(HealthDay)—For older adults with knee osteoarthritis (OA), spironolactone is not associated with improvements in symptoms, physical function, or health-related quality-of-life, according to a study published in the May ...

Jun 3, 2016

0

2

HSCT no better than chemo in Philadelphia-negative acute lymphoblastic leukemia

(HealthDay)—For patients ≥40 years of age with Philadelphia (Ph)-negative acute lymphoblastic leukemia (ALL), hematopoietic stem-cell transplantation (HSCT) in first remission is associated with lower cumulative incidence ...

Jun 3, 2016

0

0

Many addicts going without meds that curb opioid abuse

(HealthDay)—The United States is in the grip of an epidemic of opioid abuse. However, new research suggests that drugs that help addicts kick their habit after hospitalization are too seldom used.

Jun 3, 2016

0

4

Low glycemic index diet linked to drop in uric acid levels

(HealthDay)—Reducing the dietary glycemic index is associated with a reduction in uric acid levels among overweight and obese adults, according to a study published in the May issue of Arthritis & Rheumatology.

Jun 3, 2016

0

20

Hypocaloric diet, exercise both reduce visceral adiposity

(HealthDay)—Both hypocaloric diet and exercise reduce visceral adiposity (VAT), with exercise tending to have a larger effect on reducing VAT, according to a review published online May 23 in Obesity Reviews.

Jun 3, 2016

0

2

Giving chemotherapy after radiotherapy improves survival for patients with rare brain tumour

GIVING chemotherapy after radiotherapy delays further growth of a rare type of brain tumour, increasing the number of patients alive at five years from 44 per cent to 56 per cent.

Jun 3, 2016

0

0

Type 2 diabetes drug could be beneficial for head and neck cancer patients

Researchers at the University of Cincinnati (UC) College of Medicine have found that adding increasing doses of an approved Type 2 diabetes drug, metformin, to a chemotherapy and radiation treatment regimen in head and neck ...

Jun 3, 2016

Finally, targeted therapies for triple-negative breast cancer

At the American Society for Clinical Oncology (ASCO) Annual Meeting 2016, researchers present results of three clinical trials using new targeted therapies against triple negative breast cancer (TNBC). Each therapy uses a ...

Jun 3, 2016

0

3304

page 2 from 7

«
»